GLP1R and Huntington disease: These findings align with broader reviews showing that incretin hormones, including GLP-1, can cross the blood–brain barrier, regulate mitochondrial function, and mitigate oxidative stress, reinforcing their promise as therapeutic agents in HD and other neurodegenerative disorders.